C4 Therapeutics Inc Asset Turnover Ratio (CCCC), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
C4 Therapeutics Inc   (NASDAQ: CCCC)
 

C4 Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

C4 Therapeutics Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.11 in the second quarter (Jun 30 2026)

Within sector 13 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 1196 to 1203.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CCCC Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 21.2 % 4 % 23.28 % -16.48 % -7.93 %
Y / Y Revenue Change 2.75 % -15 % 112.79 % -26.9 % -46.17 %
Asset Turnover Ratio (TTM) 0.11 0.11 0.12 0.1 0.11
CCCC's Total Ranking # 1203 # 1196 # 1236 # 2999 # 2019
Seq. Asset Change 8.16 % -8.33 % 36.55 % -10.47 % -7.2 %
Seq. Revenue Change 7.95 % -44.15 % -1.91 % 73.76 % -10.71 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 14
Healthcare Sector # 103
Overall Market # 1203

Asset Turnover Ratio Statistics
High Average Low
23.06 9.69 2.98
(Sep 30 2023)   (Mar 31 2024)




CCCC Company Profile • Back to CCCC Efficiency Comparisons • Compare CCCC Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Repligen Corp  0.27 $ 785.101  Millions$ 2,938.591  Millions
Invivyd Inc   0.27 $ 58.365  Millions$ 219.167  Millions
Humacyte Inc   0.26 $ 30.074  Millions$ 114.130  Millions
Hcw Biologics Inc   0.26 $ 6.843  Millions$ 26.019  Millions
Bio rad Laboratories Inc   0.26 $ 2,589.000  Millions$ 10,078.725  Millions
Biolife Solutions Inc   0.25 $ 102.718  Millions$ 411.591  Millions
Plus Therapeutics Inc   0.24 $ 4.203  Millions$ 17.235  Millions
Revvity Inc  0.24 $ 2,911.811  Millions$ 12,087.447  Millions
Elutia Inc   0.24 $ 11.353  Millions$ 47.654  Millions
Retractable Technologies Inc  0.24 $ 33.488  Millions$ 142.089  Millions
Alpha Cognition Inc.  0.23 $ 15.261  Millions$ 64.950  Millions
Bio Green Med Solution Inc   0.23 $ 1.861  Millions$ 7.940  Millions
Personalis Inc   0.23 $ 69.669  Millions$ 303.633  Millions
Petvivo Holdings Inc   0.23 $ 1.182  Millions$ 5.211  Millions
Theravance Biopharma inc   0.23 $ 104.311  Millions$ 460.778  Millions
Biocorrx Inc   0.23 $ 0.787  Millions$ 3.478  Millions
Sutro Biopharma Inc   0.22 $ 45.702  Millions$ 204.985  Millions
Enanta Pharmaceuticals Inc  0.22 $ 65.258  Millions$ 293.260  Millions
Nutriband Inc   0.22 $ 1.618  Millions$ 7.288  Millions
Cannapharmarx Inc   0.21 $ 1.699  Millions$ 8.027  Millions
Autolus Therapeutics Plc  0.21 $ 117.390  Millions$ 567.827  Millions
Beyond Air Inc   0.21 $ 6.677  Millions$ 32.326  Millions
Ideaya Biosciences Inc   0.20 $ 234.127  Millions$ 1,158.627  Millions
Dariohealth Corp   0.20 $ 21.196  Millions$ 106.918  Millions
Safe Pro Group Inc   0.20 $ 2.881  Millions$ 14.769  Millions
60 Degrees Pharmaceuticals Inc   0.19 $ 1.111  Millions$ 5.775  Millions
Moderna Inc   0.19 $ 2,228.000  Millions$ 11,730.500  Millions
4d Molecular Therapeutics Inc   0.18 $ 92.008  Millions$ 499.053  Millions
Nrx Pharmaceuticals Inc   0.18 $ 3.394  Millions$ 18.504  Millions
Bioadaptives Inc   0.18 $ 0.026  Millions$ 0.141  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.